Insurance is Just Another Word For Nothing Left to Lose

  • by: Robert Goldberg |
  • 10/21/2016

Without commercial interruption please read this important blog from Drug Channels about how insurers and PBMs are rigging drug prices to maximize profits and discourage access.  

Insurance is -- to paraphrase the song Me and Bobby McGee -- has become another word for nothing left to lose, especially if you are one of the 4-5 percent of patients fighting cancer,  automimmune diseases and orphan conditions.   As Adam points out, the system is rigged against a minority of people.  That's discrimination.  

There is plenty of revenue from PBMSs, insurers and pharma that could be used to eliminate out of pocket spending on drugs.   that mean drug companies can charge whatever they want, as critics claim?  Hardly.   Rather it means that drug spending will have to be part of a solution that are offered to consumers based on what they value.   New medicines do not drive up health care costs long term, rather they make staying healthy more affordable and convenient.    Every economic analysis shows that.  

Instead of finger pointing about who is to blame, it's time to ramp up the shift to figuring out what value-based purchasing is and making it work.  And it's time to find more ways to reduce the cost, time and uncertainty of drug development.   Both challenges can be overcome by applying precision health tools to improve population well-being and leveraging new medicines to deliver even more value directly to people.    


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog